Cell and gene therapies: Moving from research to clinic

Journal of Translational Medicine

Volumn 8, Issue , 2010, Pages

  Stroncek, David F ^a   Puri, Raj K ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MARROW CELL; CANCER IMMUNOTHERAPY; CELL THERAPY; CHRONIC GRANULOMATOUS DISEASE; DENDRITIC CELL; EDITORIAL; GENE THERAPY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; ISCHEMIC HEART DISEASE; LEBER CONGENITAL AMAUROSIS; MEDICAL RESEARCH; MELANOMA; MESENCHYMAL STEM CELL; NATURAL KILLER CELL; REGENERATIVE MEDICINE; SEVERE COMBINED IMMUNODEFICIENCY; SICKLE CELL ANEMIA; STROMA CELL; T LYMPHOCYTE; TISSUE ENGINEERING; BIOLOGICAL THERAPY; CLINICAL TRIAL; RESEARCH;

CLINICAL TRIALS AS TOPIC; GENE THERAPY; HUMANS; RESEARCH; TISSUE THERAPY;

EID: 77952282903     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-8-31     Document Type: Editorial

References (5)

1. Lasky LC, Warkentin PI, Kersey JH, Ramsay NK, McGlave PB, McCullough J. Hemotherapy in patients undergoing blood group incompatible bone marrow transplantation. Transfusion 1983, 23:277-285. 10.1046/j.1537-2995.1983.23483276858.x, 6410549.
2. Rosenberg SA, Dudley ME. Adoptive cell therapy for the treatment of patients with metastatic melanoma. Curr Opin Immunol 2009, 21:233-240. 10.1016/j.coi.2009.03.002, 19304471.
3. Aiuti A, Roncarolo MG. Ten years of gene therapy for primary immune deficiencies. Hematology Am Soc Hematol Educ Program 2009, 682-689.
4. Herrmann JL, Abarbanell AM, Weil BR, Wang Y, Wang M, Tan J, Meldrum DR. Cell-based therapy for ischemic heart disease: a clinical update. Ann Thorac Surg 2009, 88:1714-1722. 10.1016/j.athoracsur.2009.05.079, 19853156.
5. Kode JA, Mukherjee S, Joglekar MV, Hardikar AA. Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration. Cytotherapy 2009, 11:377-391. 10.1080/14653240903080367, 19568970.